Irish patients not getting access to new medicines quickly enough says IPHA

The pharmaceutical industry claims that Irish patients are not getting access to new medicines quickly enough.

The Irish Pharmaceutical Healthcare Association says Ireland has the worst record in Europe when it comes to adopting new drugs.

The IPHA is discussing the issue at its annual conference today in Dublin.

Phillip Hannon from the IPHA says the method for deciding which drugs will be funded through by the HSE is too slow.

He said: "It is the processes that we have in terms of the reimbursement periods, the processs are wrong and I think need to be looked at.

"The minister himself said on the record in the Dail that the reimbursement system is broken."


Related Articles

Artificial intelligence could help create more specific Alzheimer’s treatment

Almost 10,000 people over 75 on trolleys in A&Es for more than 24 hours

Tool cuts epidural fail rate by over 50% at Cork hospital

Flu vaccine should be mandatory for healthcare workers, Royal College of Physicians says

More in this Section

Man, 80, and 4-year-old child hit by car in Co Antrim

Women are happier but lonelier since becoming mothers, survey shows

Woman awarded €550,000 after 'tram surfing' injury 'afraid to leave her house' following online abuse

Peter Casey: Taoiseach's comments 'deeply offensive and hurtful'


Breaking Stories

Appliance of Science: Why do bees makes hexagonal honeycombs?

Why you won't forget this new typeface

Online Lives: On the wild side with Emily Culhane

How Paddy McGurgan is using his art form to make a difference

More From The Irish Examiner